Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DE BOURCEFRANC : revenue, balance sheet and financial ratios

PHARMACIE DE BOURCEFRANC is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BOURCEFRANC-LE-CHAPUS (17560), this company of category PME shows in 2024 a net income positive of 126 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Historique financier - PHARMACIE DE BOURCEFRANC (SIREN 824320709)
Kennzahl 2024 2023 2022 2021 2020 2019 2018 2017
Umsatz N/C N/C N/C N/C N/C N/C N/C N/C
Nettoergebnis 126 305 € 200 559 € 261 004 € 244 509 € 207 118 € 226 220 € 236 850 € 53 116 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Nettomarge N/C N/C N/C N/C N/C N/C N/C N/C

Umsatz und Gewinn- und Verlustrechnung

In 2024, PHARMACIE DE BOURCEFRANC generates positive net income of 126 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 53 k€ -> 126 k€.

Nettoergebnis (2024) ?
Nettoergebnis
Definition
Bénéfice ou perte après toutes les charges, y compris impôts et éléments exceptionnels.
Formel
Ordentliches Ergebnis + Außerordentliches Ergebnis - Ertragsteuern

126 305 €

Chargement du compte de résultat...

Évolution graphique

Anzeigen :

Aktiva

Chargement des données...

Passiva

Chargement des données...

Solvenz- und Verschuldungskennzahlen

The debt ratio (= Financial debt / Equity x 100) stands at 409%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 17%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Verschuldungsgrad (2024) ?
Verschuldungsgrad
Definition
Misst das Verhältnis von Schulden zu Eigenkapital.
Formel
(Finanzschulden / Eigenkapital) x 100
Interpretation
< 50% : Faible
50-100% : Moderat
> 100% : Hoch

409.246%

Finanzielle Autonomie (2024) ?
Finanzielle Autonomie
Definition
Anteil des Eigenkapitals an der Gesamtfinanzierung.
Formel
(Eigenkapital / Bilanzsumme) x 100
Interpretation
> 30% : Gute Autonomie
20-30% : Durchschnitt
< 20% : Faible

17.322%

Anlagenaltersquote (2024) ?
Anlagenaltersquote
Definition
Misst den Abnutzungsgrad des Sachanlagevermögens.
Formel
Kumulierte Abschreibungen / Bruttoanlagevermögen x 100
Interpretation
< 50% : Neue Anlagen
50-70% : Normale Abnutzung
> 70% : Alternde Anlagen

41.3%

Entwicklung der Solvenzkennzahlen
PHARMACIE DE BOURCEFRANC

Positionnement sectoriel

Debt ratio
409.25 2024
2022
2023
2024
Q1: 16.46
Méd: 58.48
Q3: 154.77
Average +23 pts über 3 Jahre

In 2024, the debt ratio of PHARMACIE DE BOURCEFRANC (409.25) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
17.32% 2024
2022
2023
2024
Q1: 28.91%
Méd: 49.95%
Q3: 69.47%
Watch -30 pts über 3 Jahre

In 2024, the financial autonomy of PHARMACIE DE BOURCEFRANC (17.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquiditätskennzahlen

The liquidity ratio (= Current assets / Current liabilities) stands at 237.46. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquiditätsquote (2024) ?
Liquiditätsquote
Definition
Fähigkeit, kurzfristige Schulden mit dem Umlaufvermögen zu decken.
Formel
Umlaufvermögen / Kurzfristige Verbindlichkeiten
Interpretation
> 1.5 : Sehr gut
1-1.5 : Angemessen
< 1 : Risque de liquidité

237.458

Entwicklung der Liquiditätskennzahlen
PHARMACIE DE BOURCEFRANC

Positionnement sectoriel

Liquidity ratio
237.46 2024
2022
2023
2024
Q1: 129.46
Méd: 182.14
Q3: 260.79
Good -7 pts über 3 Jahre

In 2024, the liquidity ratio of PHARMACIE DE BOURCEFRANC (237.46) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Umlaufvermögensbedarf und Zahlungsfristen

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operatives Working Capital (2024) ?
Operatives Working Capital
Definition
Besoin de financement généré par le cycle d'exploitation (stocks + créances - dettes fournisseurs).
Formel
Stocks + Créances clients - Dettes fournisseurs
Interpretation
Negativ = freigesetzte Liquidität
Positiv = Finanzierungsbedarf

0 €

Kundenforderungen (2024) ?
Kundenforderungen (Tage)
Definition
Durchschnittliche Zahlungsfrist für Kunden.
Formel
(Kundenforderungen / Umsatz inkl. MwSt.) x 360
Interpretation
< 45j : Gut
45-60j : Durchschnitt
> 60j : Lang

0 j

Lieferantenverbindlichkeiten (2024) ?
Lieferantenverbindlichkeiten (Tage)
Definition
Durchschnittliche Zahlungsfrist von Lieferanten.
Formel
(Lieferantenverbindlichkeiten / Einkäufe inkl. MwSt.) x 360
Interpretation
Je länger die Frist, desto besser für die Liquidität

0 j

Lagerumschlag (2024) ?
Lagerumschlag (Tage)
Definition
Durchschnittliche Lagerdauer für Waren oder Materialien.
Formel
(Vorräte / Einkaufskosten) x 360
Interpretation
Je niedriger das Verhältnis, desto schneller der Umschlag

0 j

Entwicklung des Working Capital und der Zahlungsfristen
PHARMACIE DE BOURCEFRANC

Positionnement de PHARMACIE DE BOURCEFRANC dans son secteur

Vergleich mit der Branche Commerce de détail de produits pharmaceutiques en magasin spécialisé

Bewertungsschätzung

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DE BOURCEFRANC is estimated at 1 763 311 € (range 1 227 942€ - 2 638 014€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1227k€ 1763k€ 2638k€
1 763 311 € Range: 1 227 942€ - 2 638 014€
NAF 5 année 2024

Valuation method used

Net Income Multiple
126 305 € × 14.0x = 1 763 311 €
Range: 1 227 942€ - 2 638 014€

Only this financial indicator is available for this company.

Bewertungsentwicklung

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DE BOURCEFRANC with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DE BOURCEFRANC

What is the revenue of PHARMACIE DE BOURCEFRANC ?

The revenue of PHARMACIE DE BOURCEFRANC is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DE BOURCEFRANC profitable?

Yes, PHARMACIE DE BOURCEFRANC generated a net profit of 126 k€ in 2024.

Where is the headquarters of PHARMACIE DE BOURCEFRANC ?

The headquarters of PHARMACIE DE BOURCEFRANC is located in BOURCEFRANC-LE-CHAPUS (17560), in the department Charente-Maritime.

Where to find the tax return of PHARMACIE DE BOURCEFRANC ?

The tax return of PHARMACIE DE BOURCEFRANC is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DE BOURCEFRANC operate?

PHARMACIE DE BOURCEFRANC operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.